Right ventricle Tei-index: A tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue diseases

European Journal of Echocardiography

Volumn 8, Issue 5, 2007, Pages 317-321

  Vonk, M C ^a   Sander, M H ^a   van den Hoogen, F H J ^a   van Riel, P L C M ^a   Verheugt, F W A ^a   van Dijk, A P J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Connective tissue disease; Pulmonary arterial hypertension; RV Tei index; Systemic sclerosis

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART OUTPUT; HEART PERFORMANCE; HEART RIGHT VENTRICLE; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; LUNG WEDGE PRESSURE; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTEMIC SCLEROSIS; SYSTOLIC BLOOD PRESSURE;

CONNECTIVE TISSUE DISEASES; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY ARTERY; SYSTOLE;

EID: 34548306577     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1016/j.euje.2006.06.002     Document Type: Article

References (17)

1. Mukerjee D., St George D., Knight C., Davar J., Wells A.U., Du Bois R.M., et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology 43 (2004) 461-466
2. Barst R.J., McGoon M., Torbicki A., Sitbon O., Krowka M.J., Olschewski H., et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 43 (2004) 40S-47S
3. Steen V., and Medsger T.A. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 48 (2003) 516-522
4. Murata I., Takenaka K., Yoshinoya S., Kikuchi K., Kiuchi T., Tanigawa T., et al. Clinical evaluation of pulmonary hypertension in systemic sclerosis and related disorders - a Doppler echocardiographic study of 135 Japanese patients. Chest 111 (1997) 36-43
5. Mukerjee D., St George D., Coghlan J.G., and Black C.M. Prevalence and outcome in systemic sclerosis associated pulmonary hypertension: a four-year follow-up study. Eur Heart J 23 (2002) 490
6. Rubin L.J. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126 (2004) 4S-6S
7. Tei C., Seward J.B., Tajik A.J., Minagoe S., and Toyama Y. Index of myocardial performance - a simple and reproducible measurement of global right-ventricular myocardial-function. Circulation 92 (1995) 2834
8. Tei C., Nishimura R.A., Seward J.B., and Tajik A.J. Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr 10 (1997) 169-178
9. Giunta A., Tirri E., Maione S., Cangianiello S., Mele A., De Luca A., et al. Right ventricular diastolic abnormalities in systemic sclerosis. Relation to left ventricular involvement and pulmonary hypertension. Ann Rheum Dis 59 (2000) 94-98
10. Candell-Riera J., Armadans-Gil L., Simeon C.P., CastellConesa J., FonollosaPla V., GarciaDelCastillo H., et al. Comprehensive noninvasive assessment of cardiac involvement in limited systemic sclerosis. Arthritis Rheum 39 (1996) 1138-1145
11. Vonk M.C., van Dijk A.P.J., Heijdra Y.F., van der Heijden H.F.W., Bredie S.J.H., and van den Hoogen F.H.J. Pulmonary hypertension: its diagnosis and management, a multidisciplinary approach. Neth J Med 63 (2005) 193-198
12. Ahearn G.S., Tapson V.F., Rebeiz A., and Greenfield J.C. Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease. Chest 122 (2002) 524-527
13. Kosturakis D., Goldberg S.J., Allen H.D., and Loeber C. Doppler echocardiographic prediction of pulmonary arterial-hypertension in congenital heart-disease. Am J Cardiol 53 (1984) 1110-1115
14. Yeo T.C., Dujardin K.S., Tei C.W., Mahoney D.W., Mcgoon M.D., and Seward J.B. Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. Am J Cardiol 81 (1998) 1157-1161
15. Vonk M.C., Fransen J., Van Riel P.L.C.M., and van den Hoogen F.H.J. Do calcium channel blockers protect patients with systemic sclerosis for developing pulmonary arterial hypertension?. Ann Rheum Dis 64 (2005) 281-282
16. Vonk M.C., Fransen J., Van Riel P.L.C., and van den Hoogen F.H.J. Is prior immunosuppressive therapy protective for the development of pulmonary arterial hypertension in patients with systemic sclerosis?. Ann Rheum Dis 64 (2005) 281
17. Rich S., Dalonzo G.E., Dantzker D.R., and Levy P.S. Magnitude and implications of spontaneous hemodynamic variability in primary pulmonary-hypertension. Am J Cardiol 55 (1985) 159-163